Staphylococcus aureus vaccine conjugate pentavalent (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStaphylococcus aureus vaccine conjugate pentavalent (GlaxoSmithKline)

Drug Alias Name金黄色葡萄球菌共轭五价疫苗 - 葛兰素史克StaphVAX-PentavalentPentaStaph

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStaphylococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAviragen Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc Aviragen Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A